Patent · US Active

Gene therapy using transposon-based vectors

US8071364B2 · kind B2 · utility

11Cited by

75References

7Claims

0Family size

Assignees

TransGenRx, Inc. · US
BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE · US

Inventors

Richard K. Cooper · Baton Rouge, US
Frederick M. Enright · Baton Rouge, US
William C. Fioretti · Colleyville, US

Key dates

Filing date	Dec 24, 2004
Grant date	Dec 6, 2011
Priority date	—
Expiry date	Dec 14, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2800/90
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods and compositions are presented for the administration of transposon based vectors to an animal or human to provide gene therapy to the animal or human.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.